In this article, we will list the 5 Best Growth Stocks to Invest In for the Next 2 Years. Please visit 12 Best Growth Stocks to Invest In for the Next 2 Years to see the extended list and the methodology behind it.
5. Bloom Energy Corporation (NYSE:BE)
Number of Hedge Fund Holders: 88
Bloom Energy Corporation (NYSE:BE) is one of the best growth stocks to invest in for the next 2 years. On April 28, Bloom Energy reported a record Q1 2026, with total revenue reaching $751.1 million, a 130.4% increase compared to the $326.0 million reported in the same period last year. This performance was fueled by a 208.4% surge in product revenue, which climbed to $653.3 million. The company also achieved a positive GAAP operating income of $72.2 million, a significant turnaround from the operating loss recorded in the first quarter of 2025.
Profitability metrics showed notable improvement, with GAAP gross margin rising to 30% and non-GAAP gross margin reaching 31.5%. Service gross margins also saw a substantial year-over-year increase, jumping 12 percentage points to 13.3%. On a non-GAAP basis, operating income rose to $129.7 million, while the company generated $73.6 million in cash flow from operating activities, representing a $184.3 million improvement over the prior year’s first quarter.
Following these results, Bloom Energy Corporation (NYSE:BE) raised its full-year 2026 financial guidance, now projecting annual revenue between $3.4 billion and $3.8 billion. This updated outlook anticipates a revenue growth midpoint of ~80%, up from the previous estimate of 60%. Additionally, the company increased its non-GAAP operating income guidance to a range of $600 million to $750 million and expects non-GAAP EPS to fall between $1.85 and $2.25 for the fiscal year.
Bloom Energy Corporation (NYSE:BE) is an electrical equipment & parts company that specializes in solid oxide fuel cell systems for on-site power generation. The company also provides the Bloom Energy Server to convert fuel into electricity.
4. Quanta Services Inc. (NYSE:PWR)
Number of Hedge Fund Holders: 90
Quanta Services Inc. (NYSE:PWR) is one of the best growth stocks to invest in for the next 2 years. On April 30, Quanta Services delivered an exceptional performance for Q1 2026, setting multiple records across its financial metrics. Consolidated revenues reached a record $7.87 billion, a significant increase from $6.23 billion in the prior-year period. Net income attributable to common stock rose to $220.6 million, resulting in record Q1 GAAP diluted EPS of $1.45. On an adjusted basis, diluted EPS reached $2.68, while adjusted EBITDA climbed to $686.4 million.
The company’s project pipeline and liquidity remain at historic levels, with a record total backlog of $48.5 billion and RPO of $26.2 billion. Quanta’s cash position was equally strong, generating $391.7 million in cash flow from operations and $184.4 million in free cash flow during the quarter. CEO Duke Austin highlighted that this success is driven by the company’s unique positioning at the intersection of utility, generation, and large-load markets, which represent a massive addressable market of $2.4 trillion through the end of the decade.
For these reasons, Quanta Services Inc. (NYSE:PWR) increased its full-year 2026 financial expectations. The company now projects annual revenues to range between $34.7 billion and $35.2 billion, with adjusted diluted EPS forecasted between $13.55 and $14.25. Management expects to maintain this momentum despite potential economic headwinds such as inflation and interest rate fluctuations, remaining on track to deliver another consecutive year of double-digit earnings growth.
Quanta Services Inc. (NYSE:PWR) offers specialized infrastructure solutions to the broader utility, power generation, load center, communications, pipeline, and energy industries.
3. ASML Holding (NASDAQ:ASML)
Number of Hedge Fund Holders: 101
ASML Holding (NASDAQ:ASML) is one of the best growth stocks to invest in for the next 2 years. On May 4, ASML released a regular update regarding the execution of its current share buyback program, which was originally announced on January 28. The latest report details a series of transactions conducted between April 27 and May 1. These disclosures are made in accordance with the Market Abuse Regulation to ensure transparency for investors and regulatory authorities.
During this specific period, the company actively repurchased shares over four consecutive trading days, while no transactions were recorded on May 1. The daily volume remained steady, ranging from a low of 12,895 shares on April 27 to a high of 13,383 shares on April 29. The total value of the shares repurchased each day was remarkably consistent, with each daily expenditure totaling ~€15.87 million.
The weighted average price for these buybacks fluctuated throughout the week, starting at a high of €1,230.88 on April 27 before dipping to a low of €1,186.05 on April 29. By April 30, the average price saw a slight recovery to €1,199.81. These activities reflect ASML Holding’s (NASDAQ:ASML) ongoing commitment to its capital return strategy as outlined at the start of the 2026 fiscal year.
ASML Holding (NASDAQ:ASML) is the world’s leading manufacturer of photolithography machines, which are critical, high-tech systems used by semiconductor companies (like TSMC, Intel, and Samsung) to print tiny circuit patterns onto silicon wafers, effectively creating microchips.
2. Amphenol Corporation (NYSE:APH)
Number of Hedge Fund Holders: 103
Amphenol Corporation (NYSE:APH) is one of the best growth stocks to invest in for the next 2 years. On April 29, Amphenol delivered record-breaking results for Q1 2026, with sales reaching $7.6 billion. This represents a 58% increase in US dollars and 33% organic growth compared to the prior year, driven largely by exceptional demand in the IT datacom market. The company also reported record orders of $9.4 billion, resulting in a strong book-to-bill ratio of 1.24:1. Profitability remained high, with an adjusted operating margin of 27.3% and adjusted diluted EPS of $1.06, which rose 68% year-over-year.
Strategic expansion played a key role in the quarter’s success, highlighted by the completed acquisition of CommScope’s CCS business. CEO R. Adam Norwitt attributed the performance to the company’s expanded high-technology interconnect portfolio and its ability to capitalize on the accelerating electronics revolution. During the quarter, Amphenol returned ~$485 million to shareholders through the repurchase of 1.3 million shares and the payment of $307 million in dividends. The company maintained a strong cash position, generating $831 million in free cash flow.
For Q2 2026, Amphenol Corporation (NYSE:APH) provided an optimistic outlook, expecting sales between $8.1 billion and $8.2 billion. This forecast represents a projected increase of 43% to 45% over the same period in 2025. Adjusted diluted EPS is anticipated to fall within the range of $1.14 to $1.16, marking a significant expected increase of 41% to 43%.
Amphenol Corporation (NYSE:APH) is an electric components company that deals in electrical, electronic, and fiber optic connectors through the Communications Solutions, Harsh Environment Solutions, and Interconnect & Sensor Systems segments.
1. Eli Lilly and Company (NYSE:LLY)
Number of Hedge Fund Holders: 137
Eli Lilly and Company (NYSE:LLY) is one of the best growth stocks to invest in for the next 2 years. On April 30, Eli Lilly delivered a powerful performance for Q1 2026, with revenue surging 56% to $19.8 billion. This growth was fueled by a 65% increase in volume, led by the strong demand for the metabolic treatments Mounjaro and Zepbound, which saw worldwide revenues reach $8.7 billion and $4.1 billion, respectively. Despite lower realized prices, the company’s GAAP EPS rose by 170% to $8.26, while non-GAAP EPS reached $8.55.
The quarter was marked by regulatory and clinical milestones, most notably the FDA approval of Foundayo (orforglipron). As the only approved GLP-1 pill without food or water restrictions, Foundayo is expected to broaden patient access to obesity treatments. Lilly also advanced its pipeline with positive Phase 3 results for Jaypirca and retatrutide, and expanded its therapeutic reach through the acquisitions of Orna Therapeutics, Centessa Pharmaceuticals, Kelonia Therapeutics, and Ajax Therapeutics.
Reflecting this strong early-year momentum, Eli Lilly and Company (NYSE:LLY) increased its full-year 2026 financial guidance. The company now expects annual revenue to range between $82.0 billion and $85.0 billion, a $2 billion increase from previous estimates. Non-GAAP EPS guidance has also been raised to a range of $35.50 to $37.00.
Eli Lilly and Company (NYSE:LLY) is a healthcare company that develops human pharmaceutical products, including cardiometabolic health, oncology, and immunology products.
While we acknowledge the potential of LLY to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than LLY and that has 100x upside potential, check out our report about the cheapest AI stock.
READ NEXT: 10 Best NASDAQ Growth Stocks to Buy and Hold Forever and 10 Unstoppable Stocks That Could Double Your Money.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
